These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30689515)

  • 61. Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection.
    de Martino M; Podda A; Galli L; Sinangil F; Mannelli F; Rossi ME; Vierucci A
    Vaccine; 1997 Aug; 15(11):1235-8. PubMed ID: 9286049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.
    Nascimento IP; Dias WO; Quintilio W; Hsu T; Jacobs WR; Leite LC
    Vaccine; 2009 Dec; 27(52):7346-51. PubMed ID: 19782111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.
    Markey K; Asokanathan C; Feavers I
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31319496
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH; Tuskan RG; Lewis GK
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions.
    Werfel T; Boeker M; Kapp A
    Allergy; 1997 Apr; 52(4):465-9. PubMed ID: 9188933
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.
    Millen SH; Bernstein DI; Connelly B; Ward JI; Chang SJ; Weiss AA
    Infect Immun; 2004 Jan; 72(1):615-20. PubMed ID: 14688147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.
    Podda A; Nencioni L; Marsili I; Peppoloni S; Volpini G; Donati D; Di Tommaso A; De Magistris MT; Rappuoli R
    Vaccine; 1991 Oct; 9(10):741-5. PubMed ID: 1759492
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
    He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
    Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4(+) T cells following clinical infection.
    Han WG; Helm K; Poelen MM; Otten HG; van Els CA
    Clin Immunol; 2015 Apr; 157(2):205-15. PubMed ID: 25728491
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acellular and whole cell pertussis vaccines protect against the lethal effects of intracerebral challenge by two different T-cell dependent humoral routes.
    Wiertz EJ; Walvoort HC; Van Loveren H; Van Straaten-Van De Kappelle I; Van Der Gun JW; Kreeftenberg JG
    Biologicals; 1990 Jul; 18(3):173-80. PubMed ID: 2257130
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antigen-specific responses assessment for the evaluation of Bordetella pertussis T cell immunity in humans.
    Carollo M; Palazzo R; Bianco M; Smits K; Mascart F; Ausiello CM
    Vaccine; 2012 Feb; 30(9):1667-74. PubMed ID: 22230582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after
    Rodrigues-Neto JF; Monteiro GR; Keesen TSL; Lacerda HG; Carvalho EM; Jeronimo SMB
    Am J Trop Med Hyg; 2018 Mar; 98(3):875-882. PubMed ID: 29280433
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
    Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
    Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; De Luca EC; Contu B; Furlan R; Maida A; Moiraghi A; Stramare D; Titone L; Uxa F; Di Pisa F; Peppoloni S
    J Pediatr; 1994 Jun; 124(6):921-6. PubMed ID: 8201477
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human T cell immunity against Bordetella pertussis analyzed at clonal level.
    De Magistris MT; Rappuoli R; Tagliabue A
    Ann Ist Super Sanita; 1991; 27(1):33-6. PubMed ID: 1683526
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.
    Ryan EJ; Nilsson L; Kjellman N; Gothefors L; Mills KH
    Clin Exp Immunol; 2000 Aug; 121(2):193-200. PubMed ID: 10931131
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.
    Meyer CU; Zepp F; Decker M; Lee M; Chang SJ; Ward J; Yoder S; Bogaert H; Edwards KM
    Clin Vaccine Immunol; 2007 Mar; 14(3):288-92. PubMed ID: 17267589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.